QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
Log in
NASDAQ:VYGR

Voyager Therapeutics SEC Filings & 10K Form

$8.41
-0.28 (-3.22 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.41
Now: $8.41
$8.95
50-Day Range
$7.15
MA: $8.23
$9.28
52-Week Range
$6.26
Now: $8.41
$14.62
Volume267,269 shs
Average Volume402,536 shs
Market Capitalization$315.09 million
P/E RatioN/A
Dividend YieldN/A
Beta1.8

SEC Filings

Voyager Therapeutics (NASDAQ:VYGR) SEC Filings

DateFilerForm TypeView
01/15/2021
3:48 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2021
4:59 PM
Turenne Andre (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2021
4:57 PM
Dorval Allison (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
3:41 PM
Voyager Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/16/2020
3:17 PM
Vitale Nancy (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2020
3:14 PM
Vitale Nancy (Reporting)
Voyager Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/15/2020
3:15 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
6:47 AM
Voyager Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2020
6:18 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2020
3:40 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2020
3:18 PM
PIERCE GLENN (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:15 PM
Khwaja Omar (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
6:30 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2020
3:46 PM
Voyager Therapeutics (Filer)
Form DEF 14A
04/07/2020
4:24 PM
Hesslein Robert W. (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
7:13 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2020
4:24 PM
ARMISTICE CAPITAL, LLC (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G
02/14/2020
3:54 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
5:21 PM
Dorval Allison (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
5:20 PM
Hesslein Robert W. (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
5:20 PM
Khwaja Omar (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
5:16 PM
Turenne Andre (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
3:44 PM
VANGUARD GROUP INC (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G
02/11/2020
6:01 AM
UBS Group AG (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G/A
02/06/2020
8:10 AM
BlackRock Inc. (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G/A
01/29/2020
4:27 PM
Dorval Allison (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2020
4:26 PM
Ottmer Matthew P. (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2020
4:26 PM
Turenne Andre (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
11:15 PM
Voyager Therapeutics (Filer)
Form EFFECT
11/06/2019
6:34 AM
Voyager Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/06/2019
6:09 AM
Voyager Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
5:40 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
7:48 AM
Voyager Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
6:30 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
6:01 PM
PAUL STEVEN M (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
6:00 PM
KARSEN PERRY A (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
6:00 PM
PIERCE GLENN (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:59 PM
GERAGHTY JAMES A (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:58 PM
LEVIN MARK J (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:58 PM
Higgins Michael J (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:57 PM
Hyman Steven (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:57 PM
DIXON WENDY L (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
6:37 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
3:05 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2019
5:44 PM
Khwaja Omar (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
5:43 PM
Khwaja Omar (Reporting)
Voyager Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/21/2019
4:09 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
7:22 AM
Voyager Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
6:26 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2019
3:28 PM
Voyager Therapeutics (Filer)
Form DEF 14A
04/03/2019
8:28 PM
Hesslein Robert W. (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
8:25 PM
Hesslein Robert W. (Reporting)
Voyager Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/01/2019
3:02 PM
Partner Fund Management, L.P. (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G
03/14/2019
3:34 PM
NEUROCRINE BIOSCIENCES INC (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:31 PM
NEUROCRINE BIOSCIENCES INC (Reporting)
Voyager Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2019
4:00 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2019
4:29 PM
Voyager Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2019
7:08 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2019
2:08 PM
UBS Group AG (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G
02/14/2019
2:14 PM
ARMISTICE CAPITAL, LLC (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G/A
02/13/2019
3:02 PM
Third Rock Ventures GP III, L.P. (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G/A
02/13/2019
2:38 PM
BB BIOTECH AG (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G/A
02/13/2019
11:08 AM
FMR LLC (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G/A
02/11/2019
7:41 AM
Sanofi (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G/A
01/29/2019
6:07 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2019
8:05 PM
Turenne Andre (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2019
7:51 PM
Sah Dinah Ph.D. (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2019
7:44 PM
Ottmer Matthew P. (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2019
7:41 PM
Dorval Allison (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2018
3:20 PM
Dorval Allison (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2018
3:43 PM
Voyager Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
3:22 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2018
4:09 PM
ARMISTICE CAPITAL, LLC (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G
09/19/2018
4:41 PM
STARR KEVIN P (Reporting)
TEPPER ROBERT I (Reporting)
Third Rock Ventures GP III, L.P. (Reporting)
Third Rock Ventures III, L.P. (Reporting)
TRV GP III, LLC (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2018
4:36 PM
LEVIN MARK J (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2018
7:49 PM
GERAGHTY JAMES A (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2018
7:49 PM
PIERCE GLENN (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2018
3:05 PM
GERAGHTY JAMES A (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2018
10:16 AM
FMR LLC (Filed by)
Voyager Therapeutics (Subject)
Form SC 13G/A
08/07/2018
4:00 PM
Voyager Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2018
4:56 PM
Turenne Andre (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2018
4:51 PM
Turenne Andre (Reporting)
Voyager Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/21/2018
3:05 PM
STARR KEVIN P (Reporting)
TEPPER ROBERT I (Reporting)
Third Rock Ventures GP III, L.P. (Reporting)
Third Rock Ventures III, L.P. (Reporting)
TRV GP III, LLC (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
3:05 PM
LEVIN MARK J (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
7:50 PM
PIERCE GLENN (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
7:49 PM
Higgins Michael J (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
7:48 PM
LEVIN MARK J (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
7:48 PM
Hyman Steven (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
7:47 PM
DIXON WENDY L (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
7:46 PM
GERAGHTY JAMES A (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
7:44 PM
KARSEN PERRY A (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:15 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2018
3:15 PM
Dorval Allison (Reporting)
Voyager Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2018
3:39 PM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
6:48 AM
Voyager Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2018
6:17 AM
Voyager Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2018
6:30 AM
Voyager Therapeutics (Filer)
Form DEF 14A
04/12/2018
3:01 PM
Ravina Bernard (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2018
3:08 PM
Voyager Therapeutics (Filer)
Form CT ORDER
03/26/2018
3:02 PM
Henderson Jane (Reporting)
Voyager Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.